Sequoia Capital China and Chinese healthcare-focused investment firm HighLight Capital have backed a US$16 million series A round of financing in America-based biotechnology company Cullgen Inc., according to a statement released on Wednesday. Founded in 2018, Cullgen is a drug discovery company that utilizes ubiquitin-mediated, small molecule-induced protein degradation technology to develop targeted protein degraders […]

Sequoia China, HighLight Capital Back $16M Series A Round In US Biotech Start-Up comes originally from China Money Network. All Rights Reserved.